1. Home
  2. KNOP vs BWAY Comparison

KNOP vs BWAY Comparison

Compare KNOP & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KNOT Offshore Partners LP

KNOP

KNOT Offshore Partners LP

HOLD

Current Price

$10.40

Market Cap

346.6M

ML Signal

HOLD

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

HOLD

Current Price

$19.20

Market Cap

337.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KNOP
BWAY
Founded
2013
2003
Country
United Kingdom
Israel
Employees
N/A
N/A
Industry
Marine Transportation
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
346.6M
337.9M
IPO Year
2013
2019

Fundamental Metrics

Financial Performance
Metric
KNOP
BWAY
Price
$10.40
$19.20
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
N/A
$23.50
AVG Volume (30 Days)
121.8K
67.9K
Earning Date
12-04-2025
11-11-2025
Dividend Yield
1.00%
N/A
EPS Growth
N/A
213.09
EPS
1.17
0.13
Revenue
$352,712,000.00
$49,094,000.00
Revenue This Year
$14.84
$330.76
Revenue Next Year
$1.98
$22.24
P/E Ratio
$8.84
$59.95
Revenue Growth
17.65
27.08
52 Week Low
$5.28
$7.84
52 Week High
$10.99
$19.80

Technical Indicators

Market Signals
Indicator
KNOP
BWAY
Relative Strength Index (RSI) 51.97 63.56
Support Level $10.37 $18.31
Resistance Level $10.64 $19.80
Average True Range (ATR) 0.22 0.84
MACD -0.05 0.18
Stochastic Oscillator 30.92 83.16

Price Performance

Historical Comparison
KNOP
BWAY

About KNOP KNOT Offshore Partners LP

KNOT Offshore Partners LP owns, operates, and shuttles tankers under long-term charters in the North Sea and Brazil. The company provides crude oil loading, transportation, and storage services under time charters and bareboat charters. The Partnership is formed for acquiring ownership interests in over four shuttle tankers owned by Knutsen NYK Offshore Tankers AS (KNOT). It operates through the shuttle tanker market segment.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: